Back to search
FDAFDA · Food and drugs·Recall number D-1295-2022

Artri Ajo King Reforzado con Ortiga y Omega 3 tablets, 500 mg, 100-count bottle, Hecho en Mexico por: PLANTAS MEDICINALES DE MEXICO , Melchor Ocampo No. 55 Local D, Delegacion Xochimilco. C.P. 16800, Mexico, D.F., ASIN B092P4615M, UPC 7 501031 111190

Published July 27, 2022 · Recall initiated: May 26, 2022

Summary

FDA records drug Class I recall D-1295-2022, published July 27, 2022 and initiated May 26, 2022. Recalling firm: Amazon.com, Inc.; Status: Terminated; Reported quantity: 2,441 bottles; Lot: Lot #: LTARTKNGOMG30220, Exp. Diciembre 2025 (December 2025). Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Marketed Without An Approved NDA/ANDA: FDA laboratory analysis found the product to contain undeclared diclofenac.

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Amazon.com, Inc.
Distributor
Nationwide within the U.S.A.
Lot
Lot #: LTARTKNGOMG30220, Exp. Diciembre 2025 (December 2025).
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Artri Ajo King Reforzado con Ortiga y Omega 3 tablets, 500 mg, 100-count bottle, Hecho en Mexico por: PLANTAS MEDICINALES DE MEXICO , Melchor Ocampo No. 55 Local D, Delegacion Xochimilco. C.P. 16800, Mexico, D.F., ASIN B092P4615M, UPC 7 501031 111190 recalled?

Yes. FDA published recall D-1295-2022 on July 27, 2022. Reported hazard: Marketed Without An Approved NDA/ANDA: FDA laboratory analysis found the product to contain undeclared diclofenac.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail